metronidazole has been researched along with Stomach Neoplasms in 85 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We attempted to investigate the role of clarithromycin with tinidazole on Helicobacter pylori-related gastritis from the aspects of clinical effect and COX-2 expression." | 8.02 | Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression. ( He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X, 2021) |
| "The results are consistent with the hypothesis that tetracycline can decrease inflammation independent of a reduction in the bacterial load." | 5.09 | Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer. ( Bravo, JC; Bravo, LE; Casabon, AL; Collazos, T; Correa, P; Fischbach, LA; Ramirez, H; Realpe, JL; Ruiz, B; Schmidt, BA, 2001) |
| " We attempted to investigate the role of clarithromycin with tinidazole on Helicobacter pylori-related gastritis from the aspects of clinical effect and COX-2 expression." | 4.02 | Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression. ( He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X, 2021) |
| "Indices of platelet function, plasmic coagulation and fibrinolysis were studied during gamma-beam therapy in patients with laryngeal, gastric and cervical tumors (potentially at risk for thrombosis) against a background of metronidazole administration." | 3.67 | [Hemostasis in cancer patients during radiation therapy using metronidazole]. ( Andreev, VG; Berdov, BA; Chekalina, SI; Pavlov, VV, 1989) |
| " However, a dose-response relationship between failure rate and smoking or drinking index was found in men (all Ptrend<0." | 2.82 | A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. ( Bajbouj, M; Classen, M; Gerhard, M; Guan, WX; Li, M; Liu, RY; Liu, WD; Ma, JL; Pan, KF; Quante, M; Schmid, R; Suchanek, S; Ulm, K; Vieth, M; Wang, JX; Wang, LH; You, WC; Zhang, L; Zhang, LF; Zhang, Y; Zhou, T, 2016) |
| "To estimate risk of H." | 2.78 | Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. ( Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Sexton, R; Torres, J; Valdivieso, M, 2013) |
| "Between 1982 and 1988, MRRC RAMS carried out a prospective clinical trial of preoperative radiotherapy (20 Gy/5 days) in combination with metronidazole (given orally, 3 times, 5 gms per metre(2))." | 2.71 | Preoperative radiotherapy in combination with metronidazole for resectable gastric cancer: long-term results of a phase 2 study. ( Berdov, BA; Skoropad, VY; Zagrebin, VM, 2003) |
| "We found that the incidence of gastric cancer development at the population level was similar between participants receiving H pylori eradication treatment and those receiving placebo during a period of 7." | 2.71 | Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. ( Chen, JS; Ching, CK; Feng, RE; Fong, DY; Ho, J; Hu, WH; Lai, KC; Lam, SK; Leung, SY; Wong, BC; Wong, WM; Yuen, ST; Zheng, TT, 2004) |
| "pylori eradication therapy to prevent gastric cancer." | 2.58 | World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. ( Mori, H; Suzuki, H, 2018) |
| "Most gastroduodenal ulcers are due to HP infection." | 2.52 | [What is new in treating Helicobacter pylori infection?]. ( Fischbach, W; Glocker, E; Malfertheiner, P; Scherübl, H, 2015) |
| "pylori associated diseases such as gastric cancer is expected." | 2.50 | [Expanded indication of National Health Insurance for H. pylori associated gastritis]. ( Kato, M, 2014) |
| "Levofloxacin is an adequate substitute for clarithromycin and is recommended in second-line regimens." | 2.50 | Helicobacter pylori. ( Malfertheiner, P; Selgrad, M, 2014) |
| "All patients with peptic ulcer disease, gastric cancer, and MALT lymphoma should be tested for Hp." | 2.47 | Diagnosis and treatment of Helicobacter pylori infection. ( Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S, 2011) |
| "Amoebiasis is a parasitic infection caused by the protozoan, Entamoeba histolytica." | 1.91 | A case of fulminant amoebic colitis during systemic chemotherapy for gastric cancer. ( Doki, Y; Eguchi, H; Hamabe, A; Hata, T; Miyoshi, N; Ogino, T; Saito, T; Sekido, Y; Takiguchi, N; Uemura, M, 2023) |
| "Cultured gastric cancer cell line SGC-7901 was infected with H." | 1.56 | Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions. ( Fang, EH; Li, HJ; Tong, QS; Wang, JQ; Zheng, LD, 2020) |
| "However, the cases of stomach cancer concomitant with pyogenic liver abscess have rarely been reported in the world." | 1.46 | A Case of Advanced Gastric Cancer Concomitant with Pyogenic Liver Abscess in the Patient with Subtotal Gastrectomy. ( Heo, NY; Jeong, NR; Jeong, SJ; Nam, KH; Oh, SJ; Park, DH; Sa-Kong, H, 2017) |
| "The cumulative 5-year incidences of gastric cancer were 3." | 1.43 | Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. ( Fukayama, M; Hayakawa, Y; Hirata, Y; Koike, K; Niikura, R; Shichijo, S; Ushiku, T; Yamada, A, 2016) |
| "pylori-induced gastric cancer, irrespective of the timing of antibiotic administration." | 1.42 | Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. ( Aponte-Pieras, JR; Lee, DS; Morrissey, R; Moss, SF; Rogers, AB; Zhang, S, 2015) |
| "Fulminant amoebic colitis is very rarely associated with chemotherapy." | 1.35 | Fulminant amoebic colitis during chemotherapy for advanced gastric cancer. ( Ae, T; Hanaoka, N; Higuchi, K; Ishido, K; Koizumi, W; Saigenji, K; Sasaki, T; Tanabe, S, 2009) |
| "pylori eradication is early gastric cancer in addition to the previous indications of peptic ulcer including scar and Marginal zone B cell lymphoma (MALT type)." | 1.35 | [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. ( Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N, 2009) |
| "Although the possibility of preventing gastric cancer by eradicating H." | 1.35 | The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. ( Hirata, Y; Kawabe, T; Maeda, S; Mitsuno, Y; Ogura, K; Ohmae, T; Okamoto, M; Omata, M; Shibata, W; Watabe, H; Yamaji, Y; Yanai, A; Yoshida, H, 2008) |
| "This case emphasizes the importance of adequately dosed antibiotic therapy, also for unusual bacteria such as species of Aeromonas." | 1.33 | [Postoperative infection of an epigastric hematoma caused by Aeromonas veronii biovar sobria]. ( Bomke, AK; Feyerherd, P; Podbielski, A, 2006) |
| "pylori treatment on MALT lymphoma and chronic gastritis at the histologic and molecular levels." | 1.31 | Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases. ( Begum, S; Endo, H; Kawamata, H; Sano, T; Urakami, Y, 2000) |
| "Endoscopy after ER detected no new gastric cancers in these patients." | 1.30 | Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. ( Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S, 1997) |
| "Combined chemotherapy for human gastric cancer Transplanted into nude mice has been performed to determine whether misonidazole (MIS) and metronidazole (MTR), derivatives of nitroimidazole, would enhance the antitumor activity of MMC." | 1.27 | [Chemosensitization with nitroimidazole to human gastric cancer transplanted into nude mice]. ( Arimizu, N; Fujimoto, S; Kobayashi, K; Kokubun, M; Miyoshi, T; Mori, T; Ohta, M; Okui, K; Shrestha, RD, 1988) |
| "Hyperthermia for human gastric cancer xenotransplanted into the hindlegs of nude mice was performed to determine whether misonidazole (MISO) or metronidazole (MTR), derivatives of nitroimidazole, would intensify the antitumour effects of hyperthermia only, or combined with mitomycin C (MMC)." | 1.27 | Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles. ( Arimizu, N; Fujimoto, S; Kokubun, M; Miyoshi, T; Mori, T; Ohta, M; Okui, K; Shrestha, RD, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (15.29) | 18.7374 |
| 1990's | 17 (20.00) | 18.2507 |
| 2000's | 27 (31.76) | 29.6817 |
| 2010's | 20 (23.53) | 24.3611 |
| 2020's | 8 (9.41) | 2.80 |
| Authors | Studies |
|---|---|
| Tseng, YY | 1 |
| Liou, JM | 1 |
| Hsu, TL | 1 |
| Cheng, WC | 1 |
| Wu, MS | 1 |
| Wong, CH | 1 |
| He, C | 1 |
| Kong, F | 2 |
| Zhu, X | 1 |
| Zhao, W | 1 |
| Liu, Y | 1 |
| Wang, K | 1 |
| Takiguchi, N | 1 |
| Hata, T | 1 |
| Saito, T | 1 |
| Sekido, Y | 1 |
| Hamabe, A | 1 |
| Ogino, T | 1 |
| Miyoshi, N | 1 |
| Uemura, M | 1 |
| Doki, Y | 1 |
| Eguchi, H | 1 |
| Beheshtirouy, S | 1 |
| Eyvazi, S | 1 |
| Tarhriz, V | 1 |
| Li, HJ | 1 |
| Fang, EH | 1 |
| Wang, JQ | 1 |
| Zheng, LD | 1 |
| Tong, QS | 1 |
| Guevara, B | 1 |
| Cogdill, AG | 1 |
| Kono, Y | 1 |
| Kusumoto, C | 1 |
| Kiguchi, T | 1 |
| Okada, H | 1 |
| Kim, JL | 1 |
| Cho, SJ | 1 |
| Chung, SJ | 1 |
| Lee, A | 1 |
| Choi, J | 1 |
| Chung, H | 1 |
| Kim, SG | 2 |
| Howden, CW | 1 |
| Graham, DY | 1 |
| Suzuki, H | 1 |
| Mori, H | 1 |
| Morgan, DR | 1 |
| Torres, J | 1 |
| Sexton, R | 1 |
| Herrero, R | 1 |
| Salazar-Martínez, E | 1 |
| Greenberg, ER | 1 |
| Bravo, LE | 3 |
| Dominguez, RL | 1 |
| Ferreccio, C | 1 |
| Lazcano-Ponce, EC | 1 |
| Meza-Montenegro, MM | 1 |
| Peña, EM | 1 |
| Peña, R | 1 |
| Correa, P | 3 |
| Martínez, ME | 1 |
| Chey, WD | 1 |
| Valdivieso, M | 1 |
| Anderson, GL | 1 |
| Goodman, GE | 1 |
| Crowley, JJ | 1 |
| Baker, LH | 1 |
| Malfertheiner, P | 5 |
| Jung, HK | 1 |
| Lee, HL | 1 |
| Jang, JY | 1 |
| Lee, H | 1 |
| Kim, CG | 1 |
| Shin, WG | 1 |
| Shin, ES | 1 |
| Lee, YC | 1 |
| Kim, MS | 1 |
| Kim, N | 2 |
| Kim, SE | 1 |
| Jo, HJ | 1 |
| Shin, CM | 1 |
| Park, YS | 1 |
| Lee, DH | 1 |
| Kato, M | 1 |
| Selgrad, M | 2 |
| Tu, S | 1 |
| Yang, H | 1 |
| Scherübl, H | 1 |
| Fischbach, W | 2 |
| Glocker, E | 1 |
| Zhang, S | 1 |
| Lee, DS | 1 |
| Morrissey, R | 1 |
| Aponte-Pieras, JR | 1 |
| Rogers, AB | 1 |
| Moss, SF | 1 |
| Pan, KF | 1 |
| Zhang, L | 2 |
| Gerhard, M | 1 |
| Ma, JL | 1 |
| Liu, WD | 1 |
| Ulm, K | 1 |
| Wang, JX | 1 |
| Zhang, Y | 1 |
| Bajbouj, M | 1 |
| Zhang, LF | 1 |
| Li, M | 1 |
| Vieth, M | 1 |
| Liu, RY | 1 |
| Quante, M | 1 |
| Wang, LH | 1 |
| Suchanek, S | 1 |
| Zhou, T | 1 |
| Guan, WX | 1 |
| Schmid, R | 1 |
| Classen, M | 1 |
| You, WC | 1 |
| Grgov, S | 1 |
| Katić, V | 1 |
| Krstić, M | 1 |
| Nagorni, A | 1 |
| Radovanović-Dinić, B | 1 |
| Tasić, T | 1 |
| Zagari, RM | 1 |
| Romano, M | 1 |
| Ojetti, V | 1 |
| Stockbrugger, R | 1 |
| Gullini, S | 1 |
| Annibale, B | 1 |
| Farinati, F | 1 |
| Ierardi, E | 1 |
| Maconi, G | 1 |
| Rugge, M | 1 |
| Calabrese, C | 1 |
| Di Mario, F | 1 |
| Luzza, F | 1 |
| Pretolani, S | 1 |
| Savio, A | 1 |
| Gasbarrini, G | 1 |
| Caselli, M | 1 |
| Georgopoulos, SD | 1 |
| Papastergiou, V | 1 |
| Karatapanis, S | 1 |
| Shichijo, S | 1 |
| Hirata, Y | 2 |
| Niikura, R | 1 |
| Hayakawa, Y | 1 |
| Yamada, A | 1 |
| Ushiku, T | 1 |
| Fukayama, M | 1 |
| Koike, K | 1 |
| Park, DH | 1 |
| Heo, NY | 1 |
| Sa-Kong, H | 1 |
| Jeong, NR | 1 |
| Jeong, SJ | 1 |
| Oh, SJ | 1 |
| Nam, KH | 1 |
| Hanaoka, N | 1 |
| Higuchi, K | 1 |
| Tanabe, S | 1 |
| Sasaki, T | 1 |
| Ishido, K | 1 |
| Ae, T | 1 |
| Koizumi, W | 1 |
| Saigenji, K | 1 |
| Kim, JJ | 1 |
| Choe, YH | 1 |
| Kim, HS | 1 |
| Kim, JI | 1 |
| Chung, IS | 1 |
| Bytzer, P | 1 |
| Dahlerup, JF | 1 |
| Eriksen, JR | 1 |
| Jarbøl, DE | 1 |
| Rosenstock, S | 1 |
| Wildt, S | 1 |
| Mazzoleni, LE | 1 |
| Francesconi, CF | 1 |
| Sander, GB | 1 |
| Bornschein, J | 1 |
| Vakhrushev, IaM | 1 |
| Kniazeva, BG | 1 |
| Schuster, MJ | 1 |
| Skoropad, VY | 1 |
| Berdov, BA | 6 |
| Zagrebin, VM | 4 |
| Goebeler-Kolve, ME | 1 |
| Dragosics, B | 1 |
| Greiner, A | 1 |
| Stolte, M | 2 |
| Wong, BC | 1 |
| Lam, SK | 1 |
| Wong, WM | 1 |
| Chen, JS | 2 |
| Zheng, TT | 1 |
| Feng, RE | 1 |
| Lai, KC | 1 |
| Hu, WH | 1 |
| Yuen, ST | 1 |
| Leung, SY | 1 |
| Fong, DY | 1 |
| Ho, J | 1 |
| Ching, CK | 1 |
| Fraser, A | 1 |
| Schuster, M | 1 |
| Chen, LT | 2 |
| Lin, JT | 2 |
| Tai, JJ | 1 |
| Chen, GH | 1 |
| Yeh, HZ | 1 |
| Yang, SS | 1 |
| Wang, HP | 1 |
| Kuo, SH | 1 |
| Sheu, BS | 1 |
| Jan, CM | 2 |
| Wang, WM | 1 |
| Wang, TE | 1 |
| Wu, CW | 1 |
| Chen, CL | 2 |
| Su, IJ | 2 |
| Whang-Peng, J | 1 |
| Cheng, AL | 2 |
| Onoda, N | 1 |
| Katsuragi, K | 1 |
| Sawada, T | 1 |
| Maeda, K | 1 |
| Mino, A | 1 |
| Ohira, M | 1 |
| Ishikawa, T | 1 |
| Wakasa, K | 1 |
| Hirakawa, K | 1 |
| Bomke, AK | 1 |
| Feyerherd, P | 1 |
| Podbielski, A | 1 |
| Skoronad, VIu | 1 |
| Mardynskiĭ, IuS | 1 |
| Titova, LN | 1 |
| Ogura, K | 1 |
| Yanai, A | 1 |
| Shibata, W | 1 |
| Ohmae, T | 1 |
| Mitsuno, Y | 1 |
| Maeda, S | 1 |
| Watabe, H | 1 |
| Yamaji, Y | 1 |
| Okamoto, M | 1 |
| Yoshida, H | 1 |
| Kawabe, T | 1 |
| Omata, M | 1 |
| Tsyb, AF | 1 |
| Konopliannikov, AG | 1 |
| Kudriavtseva, GT | 1 |
| Goldobenko, GV | 1 |
| Kherkheulidze, ZSh | 1 |
| Shchebetenko, IuE | 1 |
| Polotskiĭ, BE | 1 |
| D'iakova, AM | 1 |
| Stefani, NV | 2 |
| Andreev, VG | 2 |
| Senokosov, NI | 2 |
| Pavlov, VV | 2 |
| Blecker, U | 1 |
| McKeithan, TW | 1 |
| Hart, J | 1 |
| Kirschner, BS | 1 |
| tho Pesch, S | 1 |
| Müller, W | 1 |
| Borchard, F | 1 |
| Peters, U | 1 |
| Montalban, C | 1 |
| Manzanal, A | 1 |
| Boixeda, D | 1 |
| Redondo, C | 1 |
| Bellas, C | 1 |
| Rokkas, T | 1 |
| Papatheodorou, G | 1 |
| Karameris, A | 1 |
| Mavrogeorgis, A | 1 |
| Kalogeropoulos, N | 1 |
| Giannikos, N | 1 |
| Marshall, BJ | 1 |
| Weston, AP | 1 |
| Campbell, DR | 1 |
| McGregor, DH | 1 |
| Cherian, R | 1 |
| Axon, AT | 1 |
| Davis, S | 1 |
| Muñoz, N | 1 |
| Vivas, J | 1 |
| Buiatti, E | 1 |
| Kato, I | 1 |
| Oliver, W | 1 |
| Martin, J | 1 |
| Boyle, S | 1 |
| Jacyna, M | 1 |
| Forbes, GM | 1 |
| Uemura, N | 1 |
| Mukai, T | 1 |
| Okamoto, S | 1 |
| Yamaguchi, S | 1 |
| Mashiba, H | 1 |
| Taniyama, K | 1 |
| Sasaki, N | 1 |
| Haruma, K | 1 |
| Sumii, K | 1 |
| Kajiyama, G | 1 |
| Bateson, MC | 1 |
| Winn, G | 1 |
| Ahmad, F | 1 |
| van der Hulst, RW | 1 |
| van 't Hoff, BW | 1 |
| van der Ende, A | 1 |
| Tytgat, GN | 1 |
| Rowland, M | 1 |
| Imrie, C | 1 |
| Bourke, B | 1 |
| Drumm, B | 1 |
| Ng, WW | 1 |
| Lam, CP | 1 |
| Chau, WK | 1 |
| Fen-Yau Li, A | 1 |
| Huang, CC | 1 |
| Chang, FY | 1 |
| Lee, SD | 1 |
| van Doorn, LJ | 1 |
| Bravo, JC | 2 |
| Ruiz, B | 2 |
| Realpe, JL | 2 |
| Shalom, A | 1 |
| Wasserman, I | 1 |
| Segal, M | 1 |
| Orda, R | 1 |
| Begum, S | 1 |
| Sano, T | 1 |
| Endo, H | 1 |
| Kawamata, H | 1 |
| Urakami, Y | 1 |
| Adamsson, I | 1 |
| Edlund, C | 1 |
| Nord, CE | 1 |
| Touati, E | 1 |
| Hofnung, M | 1 |
| Thiberge, JM | 1 |
| Michel, V | 1 |
| Labigne, A | 1 |
| Jenks, PJ | 1 |
| Fischbach, LA | 1 |
| Ramirez, H | 1 |
| Collazos, T | 1 |
| Casabon, AL | 1 |
| Schmidt, BA | 1 |
| Tankovic, J | 1 |
| Lamarque, D | 1 |
| Lascols, C | 1 |
| Soussy, CJ | 1 |
| Delchier, JC | 2 |
| Shyu, RY | 1 |
| Chiang, IP | 1 |
| Liu, SM | 1 |
| Alpen, B | 1 |
| Röbbecke, J | 1 |
| Wündisch, T | 1 |
| Neubauer, A | 1 |
| Levy, M | 1 |
| Copie-Bergman, C | 1 |
| Traulle, C | 1 |
| Lavergne-Slove, A | 1 |
| Brousse, N | 1 |
| Flejou, JF | 1 |
| de Mascarel, A | 1 |
| Hemery, F | 1 |
| Gaulard, P | 1 |
| Fahey, JW | 1 |
| Haristoy, X | 1 |
| Dolan, PM | 1 |
| Kensler, TW | 1 |
| Scholtus, I | 1 |
| Stephenson, KK | 1 |
| Talalay, P | 1 |
| Lozniewski, A | 1 |
| Frytak, S | 1 |
| Moertel, CH | 1 |
| Childs, DS | 1 |
| Smoot, DT | 1 |
| Scott, VF | 1 |
| Cekalina, SI | 1 |
| Guseva, LI | 1 |
| Chakŭrov, S | 1 |
| Iosifova, L | 1 |
| Karanov, S | 1 |
| Tomov, I | 1 |
| Marinova, V | 1 |
| Chekalina, SI | 1 |
| Katsalap, SN | 2 |
| Grigor'ev, AN | 1 |
| Fujimoto, S | 3 |
| Ohta, M | 3 |
| Shrestha, RD | 2 |
| Kokubun, M | 3 |
| Kobayashi, K | 2 |
| Miyoshi, T | 3 |
| Arimizu, N | 2 |
| Mori, T | 3 |
| Okui, K | 3 |
| Shresta, RD | 1 |
| Kiuchi, S | 1 |
| Arimatsu, N | 1 |
| Mizun, EP | 1 |
| Fomin, SD | 2 |
| Djakova, AM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Empirical and Genotypic Resistance Guided Tailored Therapy for Helicobacter Pylori Infection[NCT04006340] | 62 participants (Anticipated) | Interventional | 2019-01-04 | Enrolling by invitation | |||
| Comparison of Vonoprazan and Amoxicillin Dual Therapy With Standard Triple Therapy With Proton Pump Inhibitor for Helicobacter Pylori Eradication; a Randomized Control Trial[NCT04901663] | Phase 4 | 179 participants (Actual) | Interventional | 2021-06-21 | Completed | ||
| A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori[NCT01061437] | Phase 3 | 1,859 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [NCT01792700] | Phase 4 | 648 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial[NCT02541864] | 330 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection - a Randomized Controlled Trial (REHYTRI Study)[NCT02359435] | 440 participants (Actual) | Interventional | 2012-10-31 | Completed | |||
| Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type of The Stomach[NCT00201422] | 70 participants (Actual) | Interventional | 1996-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Repeated endoscopy with rapid urease test, histological examination and culture or urea breath tests are conducted to assess H. pylori status. (NCT02541864)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 154 |
| Hybrid Therapy | 154 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02359435)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Reverse Hybrid Therapy | 206 |
| Standard Triple Therapy | 191 |
21 reviews available for metronidazole and Stomach Neoplasms
| Article | Year |
|---|---|
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath | 2020 |
Gastrointestinal: Rapid emergence of double-expressor lymphoma after Helicobacter pylori eradication therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Digestive System; Follow-Up Studies; Gastric Mu | 2021 |
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; G | 2018 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gast | 2014 |
Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combinatio | 2014 |
[What is new in treating Helicobacter pylori infection?].
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combi | 2015 |
Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era.
Topics: Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Th | 2015 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, | 2011 |
[Helicobacter pylori: an infection with local complications and systemic effects].
Topics: Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Asthma; Clarithromycin; Cross-Sectional | 2011 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2002 |
[Guidelines for the diagnosis and treatment of H. pylori infection].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Duodenal Ulcer; Dysp | 2003 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis | 2004 |
[Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
Topics: Brain Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; Female; Genital Neoplasms, Female; | 1983 |
[Management of the peptic ulcer patient in the Helicobacter pylori age].
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Breath Tests; Child; Drug Therapy, Com | 1994 |
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infectio | 1994 |
Helicobacter pylori infection.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Hu | 1993 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; | 1996 |
Review: Helicobacter pylori. Current issues and new directions.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Therapy, Combination; | 1997 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1999 |
How should Helicobacter pylori infected children be managed?
Topics: Anti-Bacterial Agents; Child; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; | 2000 |
15 trials available for metronidazole and Stomach Neoplasms
| Article | Year |
|---|---|
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resi | 2020 |
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Breath | 2013 |
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2013 |
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Fr | 2013 |
A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Double-Blind Method; Drug Therapy, Combinati | 2016 |
[Conservative treatment of patients with stomach polyps].
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Gastric Acid; He | 2002 |
Preoperative radiotherapy in combination with metronidazole for resectable gastric cancer: long-term results of a phase 2 study.
Topics: Adenocarcinoma; Adult; Aged; Female; Gastrectomy; Humans; Male; Metronidazole; Middle Aged; Neoadjuv | 2003 |
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Co | 2004 |
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin | 2004 |
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin | 2004 |
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin | 2004 |
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin | 2004 |
[Use of electron acceptor compounds in radiotherapy].
Topics: Clinical Trials as Topic; Esophageal Neoplasms; Female; Humans; Laryngeal Neoplasms; Metronidazole; | 1983 |
[Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
Topics: Brain Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; Female; Genital Neoplasms, Female; | 1983 |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromyc | 1996 |
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Calcium Carbonate; Drug Therapy, | 2001 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastr | 2001 |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithro | 2002 |
50 other studies available for metronidazole and Stomach Neoplasms
| Article | Year |
|---|---|
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulc | 2014 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combinati | 2021 |
A case of fulminant amoebic colitis during systemic chemotherapy for gastric cancer.
Topics: Amebiasis; Dysentery, Amebic; Entamoeba histolytica; Humans; Metronidazole; Stomach Neoplasms | 2023 |
Evaluation of Mutations in 23S rRNA, rdxA and frxA Genes of Helicobacter pylori in Paraffin-Embedded Gastric Biopsy Specimens from Iranian Gastric Cancer and Gastritis Patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Biopsy; Clarithromycin; DNA Muta | 2021 |
Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Cell Line, Tumor; Female; Gene Expression Regulation, Neop | 2020 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistan | 2021 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal | 2013 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; | 2014 |
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Chemokine CXCL10; Chemokine CXCL9; Clarithromycin; Gastric Mucosa; G | 2015 |
Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Disease-Free Survival; Female; Heli | 2015 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bac | 2015 |
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Breath Tests; Clarithromycin; Cohort Studies; Fem | 2016 |
A Case of Advanced Gastric Cancer Concomitant with Pyogenic Liver Abscess in the Patient with Subtotal Gastrectomy.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Endoscopy, Digestive System; Ga | 2017 |
Fulminant amoebic colitis during chemotherapy for advanced gastric cancer.
Topics: Animals; Antineoplastic Agents; Antiprotozoal Agents; Dysentery, Amebic; Fatal Outcome; Humans; Inte | 2009 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked I | 2009 |
Mass eradication of Helicobacter pylori: feasible and advisable?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Ad | 2011 |
Helicobacter pylori: a historical perspective 1983-2003.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Comorbidity; Drug Therapy, Combination; Esophagitis, Peptic | 2004 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Progression; Disease-Fre | 2005 |
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer | 2005 |
[Postoperative infection of an epigastric hematoma caused by Aeromonas veronii biovar sobria].
Topics: Aeromonas; Anti-Bacterial Agents; Carcinoma, Signet Ring Cell; Cefotaxime; Gram-Negative Bacterial I | 2006 |
[Comparative assessment of immediate results of combined and surgical treatment of gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Gastrectomy; Humans; Lymph Node Excisi | 2007 |
The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents | 2008 |
[State of the liver after radiotherapy of cancer of the stomach and larynx with metronidazole radiosensitization].
Topics: Humans; Laryngeal Neoplasms; Liver; Liver Function Tests; Metronidazole; Radiation Tolerance; Stomac | 1984 |
Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child.
Topics: Adolescent; Amoxicillin; Bismuth; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Stud | 1995 |
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter I | 1994 |
Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication.
Topics: Amoxicillin; Biopsy; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B- | 1995 |
Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Bismuth; Drug Therapy, Combination; Female | 1995 |
Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infec | 1997 |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose | 1997 |
Sensitivity of Helicobacter pylori to metronidazole.
Topics: Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mic | 1997 |
Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter | 2000 |
Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Chemoprevention; Colombia; Follow-Up Studies; | 2000 |
Inflammatory fibroid polyp and Helicobacter pylori. Aetiology or coincidence?
Topics: Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans | 2000 |
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female | 2000 |
Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice.
Topics: Animals; Anti-Bacterial Agents; Biotransformation; DNA Damage; Helicobacter Infections; Helicobacter | 2000 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Dru | 2001 |
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Follo | 2001 |
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.
Topics: Agaricales; Amoxicillin; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Brassica; Clarithromycin; | 2002 |
Neurologic toxicity associated with high-dose metronidazole therapy.
Topics: Adenocarcinoma; Aged; Animals; Dogs; Female; Humans; Metronidazole; Middle Aged; Neoplasm Metastasis | 1978 |
The role of Helicobacter pylori in the pathogenesis of acid-peptic disease.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Black or African American; Dyspepsia; Gastritis; Helicobac | 1992 |
[The hemostatic homeostasis of patients with malignant neoplasms of the larynx, stomach and uterine cervix during radiotherapy and radiosensitization with metronidazole].
Topics: Combined Modality Therapy; Female; Hemostasis; Humans; Laryngeal Neoplasms; Metronidazole; Middle Ag | 1990 |
[The prevention of postoperative suppurative complications in stomach cancer].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Evaluation; Drug Therapy, Combination; Gastrectom | 1989 |
[Hemostasis in cancer patients during radiation therapy using metronidazole].
Topics: Combined Modality Therapy; Female; Hemostasis; Humans; Laryngeal Neoplasms; Metronidazole; Preoperat | 1989 |
[Use of metronidazole in the preoperative irradiation of stomach cancer patients].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Combined Modality | 1985 |
[Chemosensitization with nitroimidazole to human gastric cancer transplanted into nude mice].
Topics: Animals; Cell Division; DNA Replication; Drug Synergism; Humans; Metronidazole; Mice; Mice, Nude; Mi | 1988 |
[Enhancement of hyperthermochemotherapy with hypoxic cell radiosensitizers].
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Humans; Hyperthermia, Induced; Metronidaz | 1988 |
Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles.
Topics: Animals; Combined Modality Therapy; DNA, Neoplasm; Hyperthermia, Induced; Metronidazole; Mice; Mice, | 1988 |
[Ways of improving the methods of preoperative irradiation of patients with cancer of the stomach].
Topics: Dose-Response Relationship, Radiation; Humans; Metronidazole; Preoperative Care; Radiation-Sensitizi | 1988 |
[Characteristics of the radiation pathomorphosis of stomach cancer using metronidazole as the radiosensitizer].
Topics: Combined Modality Therapy; Humans; Metronidazole; Preoperative Care; Radiotherapy Dosage; Stomach; S | 1986 |
[Postradiogenic effect in liver tissue of patients with stomach cancer after radiosensitization with metronidazole].
Topics: Combined Modality Therapy; Humans; Liver; Metronidazole; Radiation-Sensitizing Agents; Stomach Neopl | 1985 |